Benita C. Okeke

FDA investigator

Appears on 2 documents from 2022 to 2023, mostly at sites in Florida. Most often cites testing and approval or rejection of components, drug product containers, and closures (21 CFR 211.84).

2
Documents on file
7.0
Observations per 483
2022
First seen
2023
Most recent

What they cite most

From 14 observations
  • 21 CFR 211.84
    Testing and approval or rejection of components, drug product containers, and closures
    2
  • 21 CFR 111.103
    What are the requirements under this subpart F for written procedures?
    1
  • 21 CFR 111.12(c)
    What personnel qualification requirements apply?
    1
  • 21 CFR 111.180(b)(1)
    Under this subpart G, what records must you make and keep?
    1
  • 21 CFR 111.430(b)
    Under this subpart L, what records must you make and keep?
    1
  • 21 CFR 111.453
    What are the requirements under this subpart for M written procedures?
    1

Activity by year

2022: 1, 2023: 1

Where

Florida 2

Is Benita C. Okeke coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

2 documents, newest first
FirmOpen
483 Lex IncFeb 28, 2023 · Medley, Florida
483 Miramar Cosmetics, Inc DBA Miramar LabAug 31, 2022 · Doral, Florida

About this profile

What does Benita C. Okeke inspect?

Benita C. Okeke appears on 2 documents on file covering 2 sites, mostly in Florida.

What do they cite most often?

21 CFR 211.84 (testing and approval or rejection of components, drug product containers, and closures), followed by 21 CFR 111.103 and 21 CFR 111.12(c).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Benita C. Okeke is dated Feb 28, 2023.